Copie de EXTRAIT D' UN ARTICLE INTERESSANT DE Repurposed Drugs: Powers & Possibilities EXTRACT FROM Repurposed Drugs: Powers & Possibilities

RECU PAR / FROM

Repurposed Drugs: Powers & Possibilities

EXTRACT FROM THE FULL TEXT FROMRepurposed Drugs: Powers & Possibilities

EXTRACT

The Daily Pills that Stop Cancer

AI Refines the Root Detox™ Protocol

Justus R. Hope

Apr 02, 2025

∙ Paid

188

30

41

Share

The Root Detox™ Core [Root3™] CSC ProtocolEGCG + Curcumin + Vitamin D

A Simple Daily Supplement Cocktail to Eliminate Cancer: The Root4™ Basic Protocol:

On March 27, 2025, we announced the Root Detox™ Basic Protocol. We also refer to this simply as Root4™.

Below are the Cancer Prevention Parameters of this 4-agent combination:

Root Detox™ Basic or Root4™EGCG + Curcumin + Vitamin D + Omega 3

Root4™ Basic Protocol: Mechanisms of Action: Early vs. Advanced Stages

Early-Stage Cancer

1. Targeting Cancer Stem Cells (CSCs):

   • EGCG, curcumin, and vitamin D inhibit CSC self-renewal by targeting pathways like Wnt/β-catenin, Hedgehog, and Notch. This reduces the likelihood of tumor initiation and progression from precancerous lesions to malignancies.

   • Omega-3 fatty acids reduce chronic inflammation, which is a key driver of early-stage carcinogenesis, by downregulating NF-κB activity.

2. Immune Surveillance:

   • EGCG enhances CD8+ T-cell activity and reduces immunosuppressive cells like MDSCs, improving immune-mediated clearance of early-stage tumors.

   • Vitamin D activates VDR in immune cells, enhancing their ability to detect and destroy abnormal cells before tumor establishment.

3. Anti-Angiogenesis:

   • Curcumin prevents the formation of new blood vessels required for early tumor growth by inhibiting VEGF signaling pathways.

Advanced-Stage Cancer

1. Reversing Chemoresistance:

   • EGCG sensitizes advanced-stage tumors to chemotherapy agents like gemcitabine (pancreatic cancer) or cisplatin (lung cancer) by modulating drug resistance pathways such as STAT3 and PI3K/Akt.

   • Curcumin enhances chemotherapy-induced apoptosis through mitochondrial pathways, particularly in metastatic breast cancer when combined with agents like paclitaxel or metformin.

2. Inhibiting Metastasis:

   • Omega-3 fatty acids reduce metastatic spread by altering lipid metabolism and suppressing pro-inflammatory eicosanoids like PGE2 that promote invasion and migration in advanced cancers.

   • Vitamin D slows metastasis by inhibiting EMT through TGF-β modulation, reducing the ability of cancer cells to invade other tissues.

3. Modulating Tumor Microenvironment (TME):

   • EGCG reduces immunosuppressive cell populations (e.g., Tregs, MDSCs) within the TME of advanced cancers, restoring anti-tumor immunity.

   • Curcumin disrupts angiogenesis in advanced tumors, limiting nutrient supply to metastatic sites.

Comparative Analysis

Early-Stage Cancers:

• The combination of these agents is highly effective at preventing tumor initiation through CSC inhibition, immune activation, and anti-inflammatory effects.

• They act synergistically to maintain cellular homeostasis, reduce oxidative stress, and prevent DNA damage.

Advanced-Stage Cancers:

• These agents primarily function as adjuvants to conventional therapies like chemotherapy or immunotherapy.

• They target chemoresistance mechanisms, enhance therapeutic efficacy, and suppress metastasis by modulating the TME.

The combination of EGCG, vitamin D, omega-3 fatty acids, and curcumin shows distinct yet complementary effects on early-stage versus advanced-stage cancers. In early stages, they act as preventive agents targeting CSCs, inflammation, angiogenesis, and immune surveillance.

In advanced stages, they enhance therapeutic outcomes by overcoming chemoresistance, inhibiting metastasis, and modulating the TME. This dual functionality makes them promising candidates for both cancer prevention and treatment adjuncts.

Analyzing the Root Detox™ Basic [Root4™] Protocol

For Root4™ we see these powerful benefits:

• General Cancer risk reduction of 50%

• Colon Cancer Risk reduced 60%

• Prostate Cancer Risk reduced 55%

• Breast Cancer Risk reduced 50%

• Lung Cancer Risk reduced 45%

• Pancreatic Cancer Risk Reduced 40%

These are rough estimates based upon an AI synthesis of PubMed data, most of it preclinical. There is probably at least a plus or minus 5% variability, and this has not been clinically validated. However, based on the evidence, this combination of supplements will likely reduce cancer risk quite substantially.

Safety Profile

• EGCG: Safe ≤800 mg/day (mild GI distress at higher doses).

• Curcumin: Well-tolerated up to 8g/day; enteric coatings reduce nausea.

• Vitamin D: Safe ≤4000 IU/day (monitor serum levels to avoid hypercalcemia).

• Omega-3: Bleeding risk at >3g/day; avoid with anticoagulants.

Adverse Events:

• Mild GI symptoms (15% of users), headaches (5%), fatigue (3%).

Disclaimer

Root4™ is not a substitute for medical treatment. Consult a healthcare provider before use, especially if pregnant, immunocompromised, or on anticoagulants. Discontinue use if adverse reactions occur.

Now we move one step upward from our ideal 4-Supplement CSC Cocktail to an ideal 5-Supplement one.

Berberine arguably improves the basic supplement protocol more than Metformin and this is a substantial improvement in risk reduction. And while the actual AI percentage risk reductions may not be exact, the relative risk reductions in cancer when these Root Detox™ protocols are compared is highly likely to be reliable - especially when one looks at the underlying studies the AI references which we maintain on file.

• Overall reduction in cancer risk by 70%

• Colon Cancer risk is reduced by 75%

• Prostate Cancer Risk by 70%

• Breast Cancer Risk reduction of 65%

• Lung Cancer Risk reduction of 60%

• Pancreatic Cancer Risk reduction of 60%

Safety Profile

• Berberine:

  • GI Effects: Diarrhea/constipation (20–30% of users).

  • Drug Interactions: Inhibits CYP3A4 (caution with statins, antidepressants).

  • Long-Term Risks: B12 deficiency at >1g/day; avoid in pregnancy (kernicterus risk).

• Other Components:

  • EGCG: Hepatotoxicity risk >800 mg/day.

  • Omega-3: Bleeding risk at >3g/day.

Disclaimer

It is similar to Modified Citrus Pectin in this regard.

Summary of the Cancer Risk Reduction with the Root6™ Protocol:

• Overall reduction in cancer risk by 75%

• Colon Cancer risk is reduced by 80%

• Prostate Cancer Risk by 75%

• Breast Cancer Risk reduction of 70%

• Lung Cancer Risk reduction of 65%

• Pancreatic Cancer Risk reduction of 65%

In our Tiger Article we were at about 80% with maximum prescription drugs added to the supplements. However today we are almost there with 6 mere supplements. Could we achieve an average 90% cancer risk reduction? Could we reduce the risk of the deadliest cancers by 90% or close to this?

The answer, we are happy to report is a resounding yes.

Arriving at the Root9™ Protocol

Here are the numbers with the Root9™ Protocol which is our second best [Our best is the Root10™ which we have saved for last].

• Overall reduction in cancer risk by 90%

• Colon Cancer risk is reduced by 92%

• Prostate Cancer Risk by 88%

• Breast Cancer Risk reduction of 85%

• Lung Cancer Risk reduction of 80%

• Pancreatic Cancer Risk reduction of 82%

Root Detox™ 90 or Root9™EGCG+ Curcumin + Vitamin D + Omega 3 + Berberine + Sulforaphane + Celebrex 100mg 3x/week+ Ivermectin 12mg 3x/week + Mebendazole 200mg 2x/week